As of 2026-06-29, Tango Therapeutics, Inc. (TNGX) has a 3-month relative strength percentile of 92 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 98. The current market Stance is 49 (Neutral). Sector: Healthcare. Average daily range 8.4%, relative volume 0.91×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Daily range, ATR, beta, and the math for a 1-ADR stop.
ADR% (20d)avg daily range
8.4%Elevated
ATR(14)14-day EMA
$2.22
ATR%ATR as % of close
6.83%
Beta vs SPY90d rolling
1.69
1-ADR stoprisk from close $32.56
$29.81−8.4%
COMPUTED · AS OF 2026-06-29
Pattern read
TNGX is in a stage 2 uptrend, week 3. Currently in a 9-day base; basing ADR 6.4% (broad 7.6%). VCP detected: no. RS line at new high since base start. Distance from 50d / 200d: 29.0% / 116.5%.
Pure factual computation. Not a recommendation. See stage analysis.
TNGX ranks at the 98th percentile over 1 month, 92th percentile over 3 months, 98th percentile over 6 months, 98th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities. The Classic IBD-style composite RS rating is 98. Leadership composite (price strength plus breadth) percentile: 97.
TNGX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Sector RS percentile is not available for Healthcare at this snapshot. Leading sector status (threshold: Healthcare RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
TNGX currently shows a 20-day average daily range (ADR%) of 8.4%, a 90-day beta versus the S&P 500 of 1.69. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
TickerStance computes TNGX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what TNGX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
TNGX most recently filed a 10-Q covering FY26 Q1 with the SEC on 2026-05-13. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.
§ Seasonality
10y · since 2022
Best monthJunon averageavg +36.32% · 75% win · n 4
Worst monthFebon averageavg -15.15% · 0% win · n 4